Algert Global LLC Acadia Pharmaceuticals Inc Transaction History

Algert Global LLC

$4.25 Billion
Q4 2024

A detailed history of Algert Global LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Algert Global LLC holds 485,904 shares of ACAD stock, worth $7.22 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

485,904

Previous 549,456 11.57%

Holding current value

$7.22 Million

Previous $8.45 Million 5.5%

% of portfolio

0.21%

Previous 0.23%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $908,158 - $1.19 Million	-63,552 Reduced 11.57%	485,904 $8.92 Million
Q3 2024 Nov 12, 2024	BUY	$15.14 - $19.14 $231,838 - $293,090	15,313 Added 2.87%	549,456 $8.45 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $2.63 Million - $3.31 Million	179,799 Added 50.74%	534,143 $8.68 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $1.66 Million - $2.88 Million	93,467 Added 35.83%	354,344 $6.55 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $3.1 Million - $4.74 Million	149,343 Added 133.9%	260,877 $8.17 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $7,919 - $12,718	380 Added 0.34%	111,534 $2.32 Million
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $543,078 - $782,581	-30,510 Reduced 21.54%	111,154 $2.66 Million
Q1 2023 May 12, 2023	SELL	$16.32 - $20.92 $536,193 - $687,326	-32,855 Reduced 18.83%	141,664 $2.67 Million
Q4 2022 Feb 13, 2023	SELL	$14.2 - $18.63 $45,340 - $59,485	-3,193 Reduced 1.8%	174,519 $2.78 Million
Q3 2022 Nov 15, 2022	BUY	$14.11 - $18.27 $163,407 - $211,584	11,581 Added 6.97%	177,712 $2.91 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $807,647 - $1.69 Million	62,079 Added 59.66%	166,131 $2.34 Million
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $1.42 Million - $1.86 Million	67,620 Added 185.61%	104,052 $2.52 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $274,852 - $443,463	16,370 Added 81.6%	36,432 $850,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $316,578 - $496,935	20,062 New	20,062 $333,000
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $172,562 - $379,266	-6,897 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $183,556 - $287,280	-5,040 Reduced 42.22%	6,897 $285,000
Q2 2020 Aug 12, 2020	SELL	$39.26 - $52.73 $458,242 - $615,464	-11,672 Reduced 49.44%	11,937 $579,000
Q1 2020 May 13, 2020	BUY	$31.65 - $46.87 $747,224 - $1.11 Million	23,609 New	23,609 $997,000
Q4 2019 Feb 18, 2020	SELL	$36.21 - $51.4 $266,867 - $378,818	-7,370 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $163,761 - $324,353	7,370 New	7,370 $265,000

Others Institutions Holding ACAD

# of Institutions

319

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.4B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Acadia Pharmaceuticals Inc Transaction History